What we are

what CTS does?


Chuo Translational Science LLC had been found when Reiwa Era had just come in Japan, i.e., 2019 (Reiwa 1), and since then, has been assisting clients’ development programs, fully providing our consultants’ expertise in TS and M&S technologies that have been proven as essential in many successful development programs to date, also aiming at even more robust and successful development paradigms for the new program.

In its 2nd year (2020), Yoshiro Tomono joined CTS, who is well known as the key frontier of population PK modeling in drug development in Japan, which enabled CTS to cover the wide range of Modeling & Simulation (M&S) support from discovery research to the late stage of clinical development.

To date, CTS had been committed by considerable numbers of client companies for innovative R&D challenges, and meantime, had collaborated with partner companies (see below) to co-support even more variety of clients’ programs.

These experiences enabled CTS to accumulate the sound knowledge-base as drug/therapy development consultant company, as well as to attain good access to networks of demanded resources and expertise.



CTS Partner Companies



CTS Chronology

2019Foundation of Chuo Translational Science LLC (Mar 5, 2019)
– Master Service Agreement with CMIC Co. Ltd.
– Consulting Service Agreement with NDA Partners, LLC (US)
– Consulting Service Agreement with RJR Consulting, Inc. (US)
– As CTS kick-off event, co-sponsored “Chair’s Special Seminar” in 34th Annual Congress of Japanese Society for the Study of Xenobiotics (JSSX)
2020Yoshiro Tomono joined CTS as a Pharmacometrics Expert Consultant. Population PK (PPK) modeling and simulation service by CTS has been set up, being now applied to clients’ programs.
2022Consulting Service Agreement with Ascent Development Services KK


CTS Office Location and Contact to:

Chuo Translational Science LLC
Chuo 4-24-10-501, Otaku, Tokyo 143-0024, Japan
Phone/FAX : +81 3 6435 3979

CTS Chuo Translational Science